Orna Therapeutics
Latest round
- Series B
Last raised
- Aug 2022
Total raised
- $161M
Investors
- 10
About Orna Therapeutics
Orna Therapeutics, Inc., founded in 2019 in Cambridge, US, specializes in RNA therapeutic solutions.Orna Therapeutics specializes in the development of innovative RNA therapeutics, with core products centered around engineered circular RNA (oRNA®) and lipid nanoparticle (LNP) delivery systems. These offerings target a wide array of diseases, with a focus on oncology, autoimmune diseases, and infectious diseases. The proprietary oRNA® technology enables enhanced protein expression and expanded delivery options beyond the liver, addressing conditions such as sickle-cell disease and beta-thalassemia. Their panCAR™ technology offers in vivo CAR modifications to immune cells, facilitating off-the-shelf treatment options without extensive pre-conditioning.Orna Therapeutics generates revenue through strategic partnerships with major pharmaceutical companies, such as Merck, focusing on oncology and infectious disease therapies. Revenue streams derive from milestone payments, licensing agreements, and royalties related to their proprietary products. Clients typically engage in multi-year agreements involving shared development costs and revenue-sharing models, particularly for leading products like the CD19 panCAR program targeting B cell-driven autoimmune diseases.In August 2022, Orna Therapeutics, Inc. The company intends to design and launch new products while expanding into new markets, particularly targeting enhanced presence within North America, Europe, and Asia-Pacific regions.
Who invested in Orna Therapeutics
10 investors across 2 rounds
See all investors in Orna Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Orna Therapeutics
Who invested in Orna Therapeutics?
Orna Therapeutics has 10 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Orna Therapeutics raised?
Orna Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Orna Therapeutics last raise money?
Orna Therapeutics's most recent round on record is a Series B, in Aug 2022.
What does Orna Therapeutics do?
Orna Therapeutics is a biotechnology company.
Where is Orna Therapeutics headquartered?
Orna Therapeutics is headquartered in Watertown, US.
Which VCs invest in companies like Orna Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Orna Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Orna Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.